Clinical Trial Update: Nebulized Epoprostenol (FLOLAN) and Phenylephrine on One Lung Ventilation (OLV) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating nebulized epoprostenol (FLOLAN) and phenylephrine on oxygenation during one-lung ventilation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oxygenation During One-lung Ventilation

Drugs mentioned

• Phenylephrine (phenylephrine)
• nebulized epoprostenol (FLOLAN) (epoprostenol)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Oxygenation During One Lung Ventilation | Phase 4 | Status: COMPLETED